Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Jiang: Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among.... (0.11 sec) 

Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events …

- diabetesjournals.org
R Jiang, MB Schulze, T Li, N Rifai, MJ Stampfer, EB … - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—We used Cox proportional hazard modeling to estimate the relative risk (RR) of
CVD. After adjustment for age, BMI, and other lifestyle risk factors, the multivariate RR of CVD
(the highest versus the lowest quartile) was 2.34 (95% CI 1.26–4.32) for non-HDL ...
Cited by 112 - Related articles - BL Direct - All 5 versions

Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk …


J Liu, C Sempos, RP Donahue, J Dorn, M Trevisan, … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—We used four publicly available data sets for this pooled
post hoc analysis and confined the eligible subjects to white individuals aged ≥30 years and
free of CHD at baseline (12,660 men and 6,721 women). Diabetes status was defined as ...
Cited by 54 - Related articles - BL Direct - All 6 versions

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of …

- ahajournals.org
T Pischon, CJ Girman, FM Sacks, N Rifai, MJ Stampfer, … - Circulation, 2005 - Am Heart Assoc
From the Departments of Nutrition (TP, FMS, MJS, EBR) and Epidemiology (TP, MJS, EBR), Harvard
School of Public Health, Boston, Mass; Channing Laboratory (FMS, MJS, EBR), Department
of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass; ...
Cited by 158 - Related articles - All 7 versions

[PDF] Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes


W Lu, HE Resnick, KA Jablonski, KL Jones, AK Jain … - Diabetes Care, 2003 - Am Diabetes Assoc
OBJECTIVE — To determine whether non-HDL cholesterol, a measure of total cholesterol minus
HDL cholesterol, is a predictor of CVD in patients with diabetes. ... RESEARCH DESIGN AND
METHODS — The Strong Heart Study, a population-based study of CVD and its risk ...
Cited by 166 - Related articles - BL Direct - All 10 versions

Differences between markers of atherogenic lipoproteins in predicting high …


A Simon, G Chironi, J Gariepy, MD Pino, J Levenson - Atherosclerosis, 2005 - Elsevier
Odds ratios (95% confidence interval) per standard deviation of apoB, non-HDLC, and LDLC
of having: (i) CHD risk equivalent were 1.90 (1.53–2.37), 1.78 (1.43–2.21), 1.47 (1.19–1.81);
(ii) extra-coronary plaques were 1.37 (1.16–1.61), 1.31 (1.11–1.56), 1.19 (1.01–1.39); (iii) ...
Cited by 33 - Related articles - All 8 versions

Multivariate assessment of lipid parameters as predictors of coronary heart disease …

- ahajournals.org
I Shai, EB Rimm, SE Hankinson, G Curhan, JAE … - Circulation, 2004 - Am Heart Assoc
From the Departments of Nutrition (IS, EBR, MJS) and Epidemiology (IS, EBR, SEH, JEM,
MJS), Harvard School of Public Health; Channing Laboratory (EBR, SEH, GC, JEM, MJS,
JM) and Division of Preventive Medicine (JEM, MJS), Department of Medicine, Brigham ...
Cited by 113 - Related articles - BL Direct - All 6 versions

Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as …


SM Grundy - Circulation, 2002 - Am Heart Assoc
Although low-density lipoprotein (LDL) is widely recognized as the major atherogenic lipoprotein
and the primary target of lipid-lowering therapy, 1 other lipoprotein species nonetheless appear
to be involved in atherogenesis. These include very low-density lipoproteins (VLDL), ...
Cited by 161 - Related articles - BL Direct - All 9 versions

Concordance/discordance between plasma apolipoprotein B levels and the …


AD Sniderman, AC St-Pierre, B Cantin, GR … - The American journal of …, 2003 - Elsevier
The objective of the present study was to examine concordance/discordance among 4 atherogenic
indexes of cardiovascular risk: plasma total cholesterol, low-density lipoprotein (LDL)
cholesterol, non–high-density lipoprotein (non-HDL) cholesterol, and apolipoprotein ...
Cited by 76 - Related articles - All 6 versions

Non-HDL cholesterol, apolipoproteins AI and B100, standard lipid measures, lipid …

- zhaoys.com [PDF] 
PM Ridker, N Rifai, NR Cook, G Bradwin, JE Buring - Jama, 2005 - Am Med Assoc
Objective To directly compare the clinical utility of total cholesterol, low-density lipoprotein cholesterol
(LDL-C), HDL-C, non–HDL-C, apolipoproteins AI and B 100 , high-sensitivity CRP, and the ratios
of total cholesterol to HDL-C, LDL-C to HDL-C, apolipoprotein B 100 to apolipoprotein AI, ...
Cited by 251 - Related articles - All 9 versions

Non-HDL cholesterol and apolipoprotein B in the dyslipidemic classification of type …


AM Wägner, A Pérez, E Zapico, J Ordóñez-Llanos - Diabetes Care, 2003 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—Total cholesterol and triglycerides, HDLc, LDL
cholesterol, non-HDLc, apolipoprotein B (apoB), and LDL size were determined in 122 type 2
diabetic patients (68% male, aged 59.6 ± 9.7 years, and HbA 1c 7.5% [range 5.2–16.0]). ...
Cited by 40 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google